Missing
(N=109)
PD-L1 TPS
(N=85)
P-value
Age(years)
Mean (SD) 63.8 (7.79) 63.7 (8.57) 0.432
Median [Min, Max] 66.0 [35.0, 78.0] 64.0 [33.0, 80.0]
Sex
FeMale 12 (11.0%) 9 (10.6%) 1
Male 97 (89.0%) 76 (89.4%)
Smoking
No 30 (27.5%) 18 (21.2%) 0.396
Yes 79 (72.5%) 67 (78.8%)
Pathologic subtype
Non squamous 53 (48.6%) 53 (62.4%) 0.0783
Squamous 56 (51.4%) 32 (37.6%)
PFS(months)
Mean (SD) 12.4 (7.58) 16.7 (9.42) 0.32
Median [Min, Max] 11.7 [0.367, 36.9] 14.9 [0.600, 37.4]
OS(months)
Mean (SD) 15.9 (9.18) 19.5 (9.01) 0.326
Median [Min, Max] 14.9 [0.367, 38.3] 19.4 [1.23, 39.3]
Clinical benefit
DCB 87 (79.8%) 71 (83.5%) 0.586
NDB 21 (19.3%) 14 (16.5%)
Unknown 1 (0.9%) 0 (0%)
LDH
Mean (SD) 272 (215) 202 (91.4) 0.212
Median [Min, Max] 203 [96.0, 1660] 175 [66.7, 560]
Missing 4 (3.7%) 2 (2.4%)
NLR
Mean (SD) 4.36 (2.62) 3.41 (2.07) 0.325
Median [Min, Max] 3.72 [1.04, 16.3] 2.86 [1.15, 14.0]
Missing 1 (0.9%) 1 (1.2%)
Bone metastasis
No 60 (55.0%) 50 (58.8%) 0.703
Yes 49 (45.0%) 35 (41.2%)
Brain metastasis
No 96 (88.1%) 66 (77.6%) 0.0807
Yes 13 (11.9%) 19 (22.4%)
Liver metastasis
No 91 (83.5%) 76 (89.4%) 0.33
Yes 18 (16.5%) 9 (10.6%)
Pleura metastasis
No 77 (70.6%) 63 (74.1%) 0.708
Yes 32 (29.4%) 22 (25.9%)
Lymph metastasis
No 44 (40.4%) 38 (44.7%) 0.645
Yes 65 (59.6%) 47 (55.3%)